Lubiprostone Improves Distal Segment-Specific Colonic Contractions through TRPC4 Activation Stimulated by EP3 Prostanoid Receptor
Background: Prokinetic agents are effective in increasing gastrointestinal (GI) contractility and alleviating constipation, often caused by slow intestinal motility. Lubiprostone (LUB), known for activating CLC-2 chloride channels, increases the chloride ion concentration in the GI tract, supporting...
Saved in:
Main Authors: | Byeongseok Jeong (Author), Jun Hyung Lee (Author), Jin-A Lee (Author), Seong Jung Kim (Author), Junhyung Lee (Author), Insuk So (Author), Jae Yeoul Jun (Author), Chansik Hong (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the Effect of the TRPC4/TRPC5 Blocker, ML204, in Sucrose-Induced Metabolic Imbalance
by: Mizael C. Araújo, et al.
Published: (2023) -
Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor‐dependent contractions of guinea pig gastric fundus smooth muscle
by: Keyue Xu, et al.
Published: (2022) -
Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
by: Tisha N Lunsford, et al.
Published: (2010) -
Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
by: Arpita Nag, et al.
Published: (2020) -
Prostanoid therapies in the management of pulmonary arterial hypertension
by: LeVarge BL
Published: (2015)